Abstract
Background
The Mirena levonorgestrel intrauterine system (IUS; Bayer HealthCare Pharmaceuticals)
is frequently used for menstrual suppression in adolescents with special needs. However,
the presence of a uterine anomaly is generally considered a contraindication to IUS
insertion, thereby excluding a potentially highly effective option for this patient
population.
Case
A Mirena IUS was used in a medically and surgically complex special needs 14-year-old
adolescent with a didelphys uterus and obstructed hemivagina. With the IUS inserted
into the unobstructed uterus, she achieved amenorrhea and significant reduction in
pain, with interval reduction in hematometra in the contralateral obstructed uterus.
Summary and Conclusion
We report the successful use of the Mirena IUS in a patient with a Müllerian anomaly,
supporting the use of this device in carefully selected patients.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric and Adolescent GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Canadian contraception consensus (part 3 of 4): chapter 7 - intrauterine contraception.J Obstet Gynaecol Can. 2016; 38: 182
- Menstrual management for adolescents with disabilities.Pediatrics. 2016; 138: e20160295
- The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities.BJOG. 2010; 117: 216
- Menstrual suppression in special circumstances.J Obstet Gynaecol Can. 2014; 36: 915
- Trends in menstrual concerns and suppression in adolescents with developmental disabilities.J Adolesc Health. 2013; 53: 407
- Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.J Pediatr Adolesc Gynecol. 2012; 25: 308
- Menstrual suppression for adolescents with developmental disabilities.J Pediatr Adolesc Gynecol. 2009; 22: 143
- Use of intrauterine device in the setting of uterus didelphys.Obstet Gynecol. 2006; 108: 774
- Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome: management and follow-up.Fertil Steril. 2007; 87: 918
Article info
Publication history
Published online: December 08, 2018
Footnotes
The authors indicate no conflicts of interest.
This was presented, in part, as a poster at the North American Society for Pediatric and Adolescent Gynecology Annual Clinical and Research Meeting in West Palm Beach, Florida, in April 2018.
Identification
Copyright
© 2018 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc.
